CNC Machining And Medical 3D Printing Will Drive Transformation

Published
24 Sep 24
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
US$50.00
6.8% undervalued intrinsic discount
07 Aug
US$46.62
Loading
1Y
64.6%
7D
7.5%

Author's Valuation

US$50.0

6.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on04 Aug 25
Fair value Increased 11%

The upward revision in Proto Labs' price target reflects analysts’ improved expectations for both revenue growth and net profit margins, resulting in a new fair value estimate rising from $45.00 to $50.00. What's in the News Proto Labs issued third quarter 2025 guidance, projecting revenue between $130.0 million and $138.0 million and diluted net income per share of $0.17 to $0.25.

Shared on01 May 25
Fair value Increased 1.12%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.60%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.73%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 1.96%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.